One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection

Liver Transplantation

Volumn 10, Issue 10, 2004, Pages 1240-1247

  Firpi, Roberto J ^a   Abdelmalek, Manal F ^a   Soldevila Pico, Consuelo ^a   Cabrera, Roniel ^a   Shuster, Jonathan J ^a   Theriaque, Douglas ^a   Reed, Alan I ^b   Hemming, Alan W ^b   Liu, Chen ^b   Crawford, James M ^b   Nelson, David R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOSPORIN A; GANCICLOVIR; INTERFERON; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; ALLOGRAFT; ARTICLE; CLINICAL PROTOCOL; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DEMOGRAPHY; DISEASE COURSE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HOST; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PRIORITY JOURNAL; RECURRENT VIRUS INFECTION; RISK FACTOR;

ADULT; BIOPSY, NEEDLE; DISEASE PROGRESSION; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 6444236097     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20238     Document Type: Article

References (24)

1. Center for Disease Control and Prevention. Hepatitis C Fact Sheet. Available at: http://www.cdc.gov/ncidod/diseases/hepatitis/c/index.htm. Accessed January 2004.
2. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
3. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2003;36:202-210.
4. Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, et al. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation 1997;64:422-426.
5. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992;89:1361-1365.
6. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334: 815-820.
7. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 1999;29:250-256.
8. Rosen HR, O'Reilly PM, Shackleton CR, McDiarmid S, Holt C, Busuttil RW, et al. Graft loss following liver transplantation in patients with chronic hepatitis C. Transplantation 1996;62: 1773-1776.
9. Rosen HR, Gretch DR, Oehlke M, Flora KD, Benner KG, Rabkin JM, et al. Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury. Transplantation 1998;65:1178-1182.
10. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. Donor age and outcome of liver transplantation. Hepatology 1996;24:89-96.
11. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999;117:619-625.
12. Wali M, Harrison RF, Gow PJ, Mutimer D. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut 2002;51:248-252.
13. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med 1989;321:1092-1099.
14. Makowka L, Gordon RD, Todo S, Ohkohchi N, Marsh JW, Tzakis AG, et al. Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. Transplant Proc 1987; 19:2378-2382.
15. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation 1990; 49:377-381.
16. Adam R, Astarcioglu I, Azoulay D, Morino M, Bao YM, Castaing D, et al. Age greater than 50 years is not a contraindication for liver donation. Transplant Proc 1991;23:2602-2603.
17. Alexander JW, Vaughn WK. The use of "marginal" donors for organ transplantation. The influence of donor age on outcome. Transplantation 1991;51:135-141.
18. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699.
19. International Liver Pathology Study Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-663.
20. Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, Howard R, et al. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C. Liver Transpl 2002;8:1000-1006.
21. Myers RP, Patel K, Pianko S, Poynard T, McHutchison JG. The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C. J Viral Hepat 2003;10:16-22.
22. Charlton M. The impact of advancing donor age on histologic recurrence of hepatitis C infection: the perils of ignored maternal advice. Liver Transpl 2003;9:535-537.
23. Sreekumar R, Gonzalez-Koch A, Maor-Kendler Y, Batts K, Moreno-Luna L, Poterucha J, et al. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation. Hepatology 2000;32:1125-1130.
24. Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, et al. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004;10:199-207.